Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Kojic acid
Summer 2026 Round-ups – The "Ingredients" section
What has happened over the last six months? In this “Ingredients” section of the summer Round-ups: a summary of the SCCS Opinions and ECHA’s work. On the SCCS side, a number of final Opinions are already being incorporated into a draft Regulation (Thimersal, Cannabidiol…), whilst work continues on certain fragrance ingredients (Heliotropine, Acetophenone, Cyclamen aldehyde, Cuminaldehyde, p-Cymene…) and on exposure to salicylic acid.
The CoRAP 2025-2027published by ECHA
The 28 substances included in CoRAP 2025-2027, which are suspected of posing a risk to human health or the environment, will be assessed by the competent authorities of eight Member States. This plan includes 13 new entries and 18 already present in previous CoRAPs. Of these 18, 12 have had their evaluations postponed, mainly, explains ECHA, pending new data that has been requested. Eight substances are due to be evaluated in 2025, 15 in 2026 and 5 in 2027.
UK SAG-CS Publishes Opinions on Butylated Hydroxytoluene and Kojic Acid
The UK’s SAG-CS has recently published opinions on the use of Butylated Hydroxytoluene (BHT) and Kojic Acid in cosmetic products. These opinions partially differ from those of the EU’s SCCS. In the UK, the Scientific Advisory Group on Chemical Safety in Consumer Products (SAG-CS) is acknowledged as the counterpart of EU's Scientific Committee on Consumer Safety (SCCS).
Endocrine disruptors: the regulatory challenges
The current regulatory context The definition Today, the commonly accepted definition of endocrine disruptors (EDs) is that of the WHO: “An endocrine disruptor is a substance or mixture of substances that alters the functions of the endocrine system and thereby induces adverse health effects in an intact organism, its progeny or (sub)populations.” This definition takes into account three important criteria: • The endocrine mechanism of action • The adverse effect • The causal link between the...
Two "cosmetic" ingredients added to the Candidate List
On 17 January 2022, the European Chemicals Agency (ECHA) announced that four hazardous substances had been added to the REACH Candidate List, which now has 223 entries. Among them, two can still be used in cosmetics. Under the REACH Regulation, companies have legal obligations when their substance is included – either on its own, in mixtures or in articles – in the Candidate List.
4-Methylbenzylidene Camphor : the SCCS preliminary Opinion
Monday, January 3, 2022SCCS Following the mandate given by the European Commission to the SCCS in the context of the safety assessment of substances with potential endocrine disrupting properties, the Scientific Committee has just published its preliminary Opinion on 4-Methylbenzylidene Camphor (4-MBC). It was adopted by written procedure on 22 December 2021 and is open for comments until 28 February 2022.
BHT: the SCCS final Opinion
Following the mandate given by the European Commission to the SCCS in the context of the safety assessment of substances with potential endocrine disrupting properties, the Scientific Committee has just published its final Opinion on BHT. It was adopted by written procedure on 2 December 2021. Background BHT (Butylated hydroxytoluene) (CAS No. 128-37-0, EC No. 204-881-4) is a synthetic antioxidant widely used in a variety of industries, including cosmetics.
Butylparaben, Homosalate: requests for SCCS Opinions
Tuesday, October 19, 2021SCCS Following the publication of a list of suspected endocrine disruptors to be assessed on a priority basis, and the subsequent call for data, the European Commission has now requested the SCCS for its Opinion on the safety of Butylparaben and Homosalate. Homosalate had already been the subject of an Opinion published in June 2021, this request follows new data provided by the industry. The SCCS approved these mandate by written procedure on 5 October 2021.
Homosalate: Final Opinion of the SCCS
Following the mandate given by the European Commission to the SCCS, in the framework of the evaluation of ingredients listed as endocrine disruptors, the Scientific Committee has just published its final Opinion on the safety of the UV-filter Homosalate. It was adopted at the SCCS plenary meeting on 24-25 June 2021 and is significantly different from the preliminary version.
Europe notifies WTO of its decision to identify Resorcinol as a SVHC
On 1 June 2021, the EU transmitted to the WTO a draft Implementing Decision to identify Resorcinol as a substance of very high concern under the REACH Regulation, due to its endocrine disruptor properties. This Decision is the conclusion of the safety assessment process of the substance by ECHA on the basis of the dossier submitted by France in February 2020, and should be adopted in the 4th quarter of 2021.
FEBEA reasserts that sunscreens are safe
FEBEA’s Press Release Cosmetic products, including sun protection products, are subject to extremely strict regulations, the application of which is closely monitored by both European and French health authorities. All cosmetic products and ingredients placed on the market are therefore safe for health.
Octinoxate - Ethylhexyl methoxycinnamate - Cosmetic ingredients - CosmeticOBS - L'Observatoire des Cosmétiques
Suggested reading Genistein ingrédient - 10/28/20 Trimethylbenzoyl Diphenylphosphine Oxide ingrédient - 10/28/20 Butylated Hydroxyanisole ingrédient - 2/22/21 Acetylcedrene ingrédient - 10/28/20 Homosalate ingrédient - 11/22/20 Launch of PEPPER, a platform to develop research on endocrine disruptors article - 12/9/19 Water resistance of sun protection products: the latest two ISO standards article - 11/4/20 Endocrine disruptors: why do they raise so much concern?
Oxybenzone - Benzophenone-3 - Cosmetic ingredients - CosmeticOBS - L'Observatoire des Cosmétiques
Suggested reading Resorcinol: Preliminary Opinion of the SCCS article - 11/3/20 Endocrine disruptors: the dossier article - 1/25/21 Launch of PEPPER, a platform to develop research on endocrine disruptors article - 12/9/19 Trimethylbenzoyl Diphenylphosphine Oxide ingrédient - 10/28/20 France launches its second national strategy on endocrine disruptors article - 9/4/19 Benzophenone ingrédient - 10/28/20 Genistein ingrédient - 10/28/20 Salicylic Acid ingrédient - 12/12/20 Endocrine disruptors:...
Resorcinol - Resorcinol - Cosmetic ingredients - CosmeticOBS - L'Observatoire des Cosmétiques
Antioxidant Denaturant Hair Dyeing Perfuming State of the regulations Lorem ipsum dolor sit amet, consectetur adipiscing elit. Proin hendrerit eget arcu at pulvinar. Etiam magna metus, maximus a faucibus vel, rutrum ac urna. Sed tempus dolor ac diam placerat, eu imperdiet est pharetra. Vestibulum sagittis ante diam, sit amet vulputate enim dapibus quis. Nullam odio est, ornare ac varius id, blandit suscipit lectus. Nunc mattis lobortis neque, sit amet vulputate massa ullamcorper at.
Butylphenyl Methylpropional
Suggested reading Triclocarban ingrédient - 10/28/20 Enzacamene ingrédient - 10/28/20 Limonene and Linalool hydroperoxides: Exposure source for skin sensitizing remains elusive article - 4/9/19 Cyclomethicone ingrédient - 10/28/20 Endocrine disruptors explained by the FEBEA (2/3) article - 2/26/19 Tert-Butyl Methyl Ether ingrédient - 10/28/20 Benzophenone ingrédient - 10/28/20 Genistein ingrédient - 10/28/20 Triclosan ingrédient - 10/28/20 Launch of PEPPER, a platform to develop research on...
Benzyl Salicylate
Suggested reading α-Amylcinnamaldehyde ingrédient - 10/28/20 Benzotriazole ingrédient - 10/28/20 Endocrine disruptors: why do they raise so much concern?
Endocrine disruptors: 2nd call for data from the European Commission
The European Commission is continuing its process of assessing the safety of potential endocrine disruptors used in cosmetic products. On 15 February 2021, it launched a new call for data on 10 substances, including two parabens, five UV filters, BHA and salicylic acid. A first call for data was launched in May 2019 for 14 other substances.
Kojic acid: Side effects and benefits
Kojic acid is sometimes used in the food industry as a natural preservative. One of the main uses of kojic acid, however, is in some health and cosmetic products. In this article, we look at how kojic acid is used, what possible health benefits it might have, and what the potential risks and side effects are. Kojic acid is sometimes used in health and beauty products to lighten the skin. It may be used to treat skin conditions, such as sun damage, scars, and age spots.
Inception consultation on the revision of Cosmetics Regulation
On 4 October 2021, the European Commission launched a first consultation to assess the impacts of the upcoming revision of the Cosmetics Regulation 1223/2009. The proposal under consideration includes the extension of the generic approach to risk management to endocrine disruptors, the reallocation of the tasks of the SCCS to ECHA, the revision of the definition of nanomaterials and digital labelling. It is open until 1 November 2021.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Kojic
Contact Kojic, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack